Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 616-020-3 | CAS number: 7381-13-7
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- 1,1'-(1,3-Phenylenedicarbonyl)diazepan-2-one
- EC Number:
- 616-020-3
- Cas Number:
- 7381-13-7
- Molecular formula:
- C20H24N2O4
- IUPAC Name:
- 1,1'-(1,3-Phenylenedicarbonyl)diazepan-2-one
- Details on test material:
- none
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Centre de Production Animale (F-45160 Olivet)
- Age at study initiation: 5-6 weeks
- Weight at study initiation: 294 g - 413 g
- Temperature : between 19°C and 24°C
- Relative humidity : between 39% and 60%
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- paraffin oil
- Concentration / amount:
- Induction phase:
test item at 60% in liquid paraffin (Day 0)
test item at 60% in liquid paraffin, 24 hours after brushing with a solution of sodium Iauryl sulfate (Day 7)
Challenge phase: test item has been used at diluted 60% and 30% in liquid paraffin
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- Induction phase:
test item at 60% in liquid paraffin (Day 0)
test item at 60% in liquid paraffin, 24 hours after brushing with a solution of sodium Iauryl sulfate (Day 7)
Challenge phase: test item has been used at diluted 60% and 30% in liquid paraffin
- No. of animals per dose:
- GROUP 1 (negative control group) : 5 male guinea pigs
GROUP 2 (treated group) : 11 male guinea pigs - Details on study design:
- RANGE FINDING TESTS:
1) Maximum Non Necrotizing Concentration (M.N.N.C.) determination:
The test item should be freshly prepared in view to obtain a maximum non necrotising concentration
for injection by intradermal route.
So, the different concentrations 10% to 0.3 125% have being prepared using olive oil as vehicle. At these concentrations, the test item was insoluble. Indeed, some particJes stayed in the preparation and the injections were not possible even with more suitable needles (23G x I", 0.6x25 mm). Therefore, in accordance with the experimental protocol, the first induction was made topically over 48 hours under
occJusive dressing after 4 intradermal injections of Freund's Complete Adjuvant diluted at 50%.
2) Pre-Maximum Non Irritant Concentration (pre-M.N.I.C.) determination:
2 guinea pigs identified n° C7767 & C7768. The test item was applied under an occJusive dressing during 24 hours, at the following concentrations diluted at 60%, 30%, 15 and 7.5% in liquid paraffin.
3) Maximum Non Irritant Concentration (M.N.I.C.) determination:
3 guinea pigs identified n° C7572 to C7574.
After induction by two topical applications with liquid paraffin and a 11-day rest phase, the challenge phase under occIusive dressing for 24 hours consists in a single topical application of the test item at the following concentrations: diluted at 60%, 30%, 15 and 7.5% in liquid paraffin.
MAIN STUDY
A. INDUCTION EXPOSURE (Group 1)
1st Induction:
- 4 intraderrnal injections of Freund's Complete Adjuvant diluted at 50% in a physiological saline solution.
- 3 scarifications perforrned between injection sites.
- topical application during 48 hours, on the same zone, under occlusive dressing with the test item at 60%.
- Exposure period: 48 hours
2nd induction:
topical application, on the same zone, with the test item at 60%, 24 hours after brushing with 0.5 mL of a solution of Sodium lauryl sulfate at 10%.
B. CHALLENGE EXPOSURE (Groups 1 & 2):
topical application under occlusive dressing at the following concentrations: 60% & 30%.
- Evaluation (hr after challenge): 24 hour reading time; 48-hour reading time and weighing - Challenge controls:
- Overall results (readings at 24 and 48 hours)
- Positive control substance(s):
- yes
- Remarks:
- Freund's Complete Adjuvant (FCA)
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 60% Concentration
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 60% Concentration. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 30% concentration
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 30% concentration. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 60% concentration
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 60% concentration. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 30 % concentration
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 30 % concentration. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 60% concentration
- No. with + reactions:
- 0
- Total no. in group:
- 11
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 60% concentration. No with. + reactions: 0.0. Total no. in groups: 11.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 60% concentration
- No. with + reactions:
- 0
- Total no. in group:
- 11
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 60% concentration. No with. + reactions: 0.0. Total no. in groups: 11.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 30% concentration
- No. with + reactions:
- 0
- Total no. in group:
- 11
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 30% concentration. No with. + reactions: 0.0. Total no. in groups: 11.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 30% concentration
- No. with + reactions:
- 0
- Total no. in group:
- 11
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 30% concentration. No with. + reactions: 0.0. Total no. in groups: 11.0. Clinical observations: none.
Any other information on results incl. tables
Weight evolution:
Not any abnormality was recorded in the body weight gain of both groups.
Mortality:
No mortality occurred during this study.
No macroscopic cutaneous reactions attributable to allergy were recorded during the examination following the removal of the occlusive dressing (challenge phase) from the animals of the treated group with the test item.
No cutaneous intolerance reaction was recorded in animals from the negative control group.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- not to be classified
- Executive summary:
After induction of 11 Guinea Pigs of the treated group by 2 topical applications with the test item diluted at 60% in liquid paraffin during 48 hours, and a II-day rest phase, the challenge phase, und er occJusive dressing for 24 hours, consisted to a single topical application of the test item diluted at 60% and at 30% in liquid paraffin.
No macroscopic cutaneous reactions attributable to allergy were recorded during the examination following the removal of the occlusive dressing (challenge phase) from the animals of the treated group with the test item.
No cutaneous intolerance reaction was recorded in animals from the negative control group.
Weight evolution:
Not any abnormality was recorded in the body weight gain of both groups.
Mortality:
No mortality occurred during this study.
No macroscopic cutaneous reactionsattributable to allergy were recorded during the examination following the removal of the occlusive dressing (challenge phase) from the animals of the treated group with the test item.
No cutaneous intolerance reaction wasrecorded in animals from the negative control group.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
